NewsWhore
12-16-2010, 05:50 PM
The PATH Malaria Vaccine Initiative (MVI), pharmaceutical company Merck and New York University's Langone Medical Center on Tuesday announced they were collaborating "to develop a vaccine capable of p...
More... (http://story.brazilsun.com/index.php/ct/9/cid/24437442923341f1/id/41310636/)
More... (http://story.brazilsun.com/index.php/ct/9/cid/24437442923341f1/id/41310636/)